Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy

Controlled Trial ◽

Hormone Analogue ◽

Releasing Hormone ◽

Cancer Outcome ◽

Maximal Androgen Blockade ◽

A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer

Urology ◽

10.1016/s0090-4295(99)80368-9 ◽

1995 ◽

Vol 46 (6) ◽

pp. 899 ◽

Cited By ~ 2

Author(s):

E. David Crawford

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Controlled Trial ◽

Hormone Analogue ◽

A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer

Urology ◽

10.1016/s0090-4295(99)80077-6 ◽

1995 ◽

Vol 45 (5) ◽

pp. 745-752 ◽

Cited By ~ 91

Author(s):

Paul Schellhammer ◽

A. Lynn Patterson ◽

Roohollah Sharifi ◽

Michael Sarosdy ◽

Norman Block ◽

...

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Controlled Trial ◽

Hormone Analogue ◽

A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer

Urology ◽

10.1016/s0090-4295(96)80033-1 ◽

1996 ◽

Vol 48 (4) ◽

pp. 661-662

Author(s):

M. Zerbib ◽

C. Payan

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Controlled Trial ◽

Hormone Analogue ◽

The Cost-Effectiveness of Combined Androgen Blockade With Bicalutamide and Luteinizing Hormone Releasing Hormone Agonist in Men With Metastatic Prostate Cancer

Yearbook of Urology ◽

10.1016/s0084-4071(08)70376-2 ◽

2006 ◽

Vol 2006 ◽

pp. 211-212

Author(s):

J.T. Wei

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Luteinizing Hormone ◽

Releasing Hormone ◽

The Cost ◽

456 A randomized double-blind trial in 813 previously untreated metastatic prostate cancer (CaP) patients (PTS) comparing a new antiandrogen casodex® (bicalutamide) with eulexin (flutamide) in combination with luteinizing hormone releasing hormone analogue (LHRH-a) therapy

European Journal of Cancer ◽

10.1016/0959-8049(95)95710-n ◽

1995 ◽

Vol 31 ◽

pp. S98

Author(s):

N.J. Vogelzang ◽

P.F. Schellhammer ◽

R. Sharifi ◽

N.L. Block ◽

M.S. Soloway ◽

...

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Double Blind Trial ◽

Hormone Analogue ◽

Double Blind ◽

Releasing Hormone ◽

Blind Trial

Therapeutic effects of the combined androgen blockade therapy versus luteinizing hormone-releasing hormone analog monotherapy in patients with hormone naïve metastatic prostate cancer: a multi-institutional comparative analysis

Translational Andrology and Urology ◽

10.21037/tau-20-966 ◽

2021 ◽

Vol 10 (1) ◽

pp. 417-425

Author(s):

Takuma Narita ◽

Shingo Hatakeyama ◽

Shintaro Narita ◽

Masahiro Takahashi ◽

Toshihiko Sakurai ◽

...

Keyword(s):

Prostate Cancer ◽

Comparative Analysis ◽

Luteinizing Hormone ◽

Therapeutic Effects ◽

Releasing Hormone ◽

Hormone Analog ◽

THE COST-EFFECTIVENESS OF COMBINED ANDROGEN BLOCKADE WITH BICALUTAMIDE AND LUTEINIZING HORMONE RELEASING HORMONE AGONIST IN MEN WITH METASTATIC PROSTATE CANCER

The Journal of Urology ◽

10.1097/01.ju.0000165569.48372.4c ◽

2005 ◽

Vol 174 (2) ◽

pp. 547-552 ◽

Cited By ~ 22

Author(s):

DAVID F. PENSON ◽

SCOTT RAMSEY ◽

DAVID VEENSTRA ◽

LAUREN CLARKE ◽

SANJAY GANDHI ◽

...

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Luteinizing Hormone ◽

Releasing Hormone ◽

The Cost ◽

566 ANAMEM: Prospective and observational study to evaluate cognitive changes in prostate cancer patients undergoing luteinizing hormone-releasing hormone analogue treatment

European Urology Supplements ◽

10.1016/s1569-9056(15)60559-0 ◽

2015 ◽

Vol 14 (2) ◽

pp. e566-e566a

Author(s):

J. Morote ◽

A. Tabernero ◽

M.J. Ledo ◽

J.P. Ciria ◽

J.L. Domínguez-Escrig ◽

...

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Observational Study ◽

Cancer Patients ◽

Hormone Analogue ◽

Cognitive Changes ◽

MP73-01 ANAMEM: PROSPECTIVE AND OBSERVATIONAL STUDY TO EVALUATE COGNITIVE CHANGES IN PROSTATE CANCER PATIENTS UNDERGOING LUTEINIZING HORMONE-RELEASING HORMONE ANALOGUE TREATMENT

The Journal of Urology ◽

10.1016/j.juro.2015.02.2677 ◽

2015 ◽

Vol 193 (4S) ◽

Author(s):

Juan Morote ◽

Ángel Tabernero ◽

José Luis Álvarez-Ossorio ◽

Juan Pablo Ciria ◽

José Luis Domínguez-Escrig ◽

...

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Observational Study ◽

Cancer Patients ◽

Hormone Analogue ◽

Cognitive Changes ◽

Extended analyses: Combined androgen blockade (CAB) therapy with bicalutamide vs. luteinizing hormone-releasing hormone agonist (LHRHa) monotherapy in Japanese men with untreated advanced prostate cancer

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.5063 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 5063-5063 ◽

Cited By ~ 3

Author(s):

H. Akaza ◽

S. Hinotsu ◽

M. Usami ◽

Y. Arai ◽

H. Kanetake ◽

...

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Japanese Men ◽

Releasing Hormone ◽